Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
about
Antimalarial drug resistance: An overviewGenomic analysis of local variation and recent evolution in Plasmodium vivax.Multiple Origins of Mutations in the mdr1 Gene--A Putative Marker of Chloroquine Resistance in P. vivaxWhole Genome Sequencing of Field Isolates Reveals Extensive Genetic Diversity in Plasmodium vivax from ColombiaEmerging Plasmodium vivax resistance to chloroquine in South America: an overviewGenetic diversity in new members of the reticulocyte binding protein family in Thai Plasmodium vivax isolatesDeterminants of in vitro drug susceptibility testing of Plasmodium vivax.A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, PakistanAmplification of pvmdr1 associated with multidrug-resistant Plasmodium vivaxama1 genes of sympatric Plasmodium vivax and P. falciparum from Venezuela differ significantly in genetic diversity and recombination frequency.Resistance to therapies for infection by Plasmodium vivaxAssessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literatureChloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India.Single-nucleotide polymorphism, linkage disequilibrium and geographic structure in the malaria parasite Plasmodium vivax: prospects for genome-wide association studies.In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivaxGenetic diversity and natural selection of Plasmodium vivax multi-drug resistant gene (pvmdr1) in Mesoamerica.Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trialExpression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon.A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development.Replication of Plasmodium in reticulocytes can occur without hemozoin formation, resulting in chloroquine resistance.In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.Plasmodium vivax isolates from Cambodia and Thailand show high genetic complexity and distinct patterns of P. vivax multidrug resistance gene 1 (pvmdr1) polymorphisms.Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.Therapeutic efficacy of chloroquine in Plasmodium vivax and the pvmdr1 polymorphisms in the Republic of Korea under mass chemoprophylaxis.Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistance.Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central ChinaCharacterization of treatment failure in efficacy trials of drugs against Plasmodium vivax by genotyping neutral and drug resistance-associated markers.Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.A new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes.Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat.Polymorphisms in chloroquine resistance-associated genes in Plasmodium vivax in Ethiopia.Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America.Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013.Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.Sensitive Detection of Plasmodium vivax Using a High-Throughput, Colourimetric Loop Mediated Isothermal Amplification (HtLAMP) Platform: A Potential Novel Tool for Malaria Elimination.Failure of Supervised Chloroquine and Primaquine Regimen for the Treatment of Plasmodium vivax in the Peruvian Amazon.
P2860
Q26753085-45DC1798-3205-434C-A701-CF7149F303D8Q27149930-ACDC0F8F-AFB0-4467-8153-260C2D596434Q28550721-A7D9F9EF-A28E-492A-901D-547ADAF28841Q28551791-F5AD24FF-6C3B-4D84-B88A-3CE09151279DQ28655984-7FD40C3F-5D31-447A-B22D-229A8D90D1BFQ28731528-72FDC813-6AB5-4E2F-B877-04C99309902AQ33313565-AD41322B-0A09-45C8-B73B-F7B4A5E23AD6Q33358051-7823E4D9-D04F-4B48-8F5E-131E12F11BC1Q33371043-C5B3346E-5772-4523-BA35-80DB6AF41E4AQ33375053-EF07BDCC-DAD0-4B15-9C4F-7980B563568BQ33481576-7284E80B-CEE0-40FC-86D8-3EEFF6D7CBA1Q33577218-7A58FCBF-75EE-4A27-8D59-538B1087DA4DQ33612286-E13D7784-816C-4608-A3F1-D1F8F6D8859FQ33631643-DD730DC8-983E-413B-89ED-A61E79169279Q33704762-D59BB063-1AB8-4D90-B3BC-113AD2D0407BQ33764147-1F29B13D-0544-430D-B16D-F40B15CF5C01Q33861768-4F85847B-2C39-47D0-8D71-4B0068C97072Q34049080-44599271-373F-494F-AE07-AA67167925E7Q34089944-79F8E5F0-6F6A-4373-AC80-D9E856A9E2DDQ34166626-0B486854-A898-4715-8DD5-B59EF280F4AAQ34475026-F7A735F9-9A0E-467E-B524-516BAA884FE8Q34596770-2E1E380C-8697-488B-A415-5FD2256974E0Q34627183-A66702DE-3415-456E-A004-15B9F88874B6Q34660024-9D67D8FE-61EA-4A6B-85A1-261042CF9678Q34707766-0FBBC7ED-35AD-4BFA-BB2E-6693F519048CQ34710568-8ED56CB3-ED41-42AC-993E-B9CB3E7A4935Q34826216-4599B9F8-E225-4201-9B6A-3F38357DC96BQ35131344-87A78FAF-9B10-4411-867A-C2C1335714E0Q35191546-31EDCDB6-916A-4EEB-AC83-437B4FD5BD75Q35191550-7876F024-F2D6-4E32-B157-9AD1F2FB8AD1Q35338795-D3112568-A395-445B-90A5-2859EC7309E0Q35358158-D69056DF-92F9-4EF8-B676-6A9ED92D6C31Q35497890-761C820E-451F-4AC7-B4EF-FC985E08A2C0Q35684833-B1716015-8ED2-40AC-94DE-854C3C26009AQ35698213-4506C390-CA58-47D4-AB10-D22349187289Q35814367-1F6EA7AD-D5F4-4D82-9D20-0E23B5D89182Q35829555-FD0DC7DA-66F8-4E5B-AC99-299B060F53E0Q35830639-8DCC22BF-5FC7-411A-A34F-7BACEC810424Q35921902-4F3877F4-C607-44C7-8D8B-D0D53AB5D72CQ36020650-64D55041-47CE-413B-B7F9-E5433211977D
P2860
Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Chloroquine resistant Plasmodi ...... with molecular polymorphisms.
@ast
Chloroquine resistant Plasmodi ...... with molecular polymorphisms.
@en
Chloroquine resistant Plasmodi ...... with molecular polymorphisms.
@nl
type
label
Chloroquine resistant Plasmodi ...... with molecular polymorphisms.
@ast
Chloroquine resistant Plasmodi ...... with molecular polymorphisms.
@en
Chloroquine resistant Plasmodi ...... with molecular polymorphisms.
@nl
prefLabel
Chloroquine resistant Plasmodi ...... with molecular polymorphisms.
@ast
Chloroquine resistant Plasmodi ...... with molecular polymorphisms.
@en
Chloroquine resistant Plasmodi ...... with molecular polymorphisms.
@nl
P2093
P2860
P50
P1433
P1476
Chloroquine resistant Plasmodi ...... with molecular polymorphisms.
@en
P2093
Alan Brockman
Budi Prasetyorini
Ferryanto Chalfein
Kim A Piera
Marina Chavchich
Marion Barends
Rossarin Suwanarusk
Usa Lek-Uthai
Varakorn Kosaisavee
P2860
P356
10.1371/JOURNAL.PONE.0001089
P407
P577
2007-10-31T00:00:00Z